Identifying Deceptive Rx Advertising: FDA Rejects PhRMA's Criticisms Of Its Study
US agency disagrees that study of consumer and healthcare professional ability to detect deceptive promos is unnecessary; final guidance on product name placement in labeling and advertisements mirrors 2013 draft.
